BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 27592361)

  • 1. Protective effects of agonistic anti-4-1BB antibody on the development of imiquimod-induced psoriasis-like dermatitis in mice.
    Yoo JK; Choo YK; Kwak DH; Lee JM; Lim CY; Lee JH; Park MY; Kim CH
    Immunol Lett; 2016 Oct; 178():131-9. PubMed ID: 27592361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
    Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
    Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic anti-psoriatic effects of myeloid-derived suppressor cells in combination with systemic tacrolimus (FK-506) in an imiquimod-induced mouse model of psoriasis.
    Park MY; Choo YK; Jeon SH; Jang WG; Lee JH; Park JH; Kim CH
    Int Immunopharmacol; 2020 Sep; 86():106553. PubMed ID: 32563057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of acarbose ameliorates imiquimod-induced psoriasis-like dermatitis in a mouse model.
    Chen HH; Chao YH; Chen DY; Yang DH; Chung TW; Li YR; Lin CC
    Int Immunopharmacol; 2016 Apr; 33():70-82. PubMed ID: 26874324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine.
    Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK
    Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.
    Qin S; Wen J; Bai XC; Chen TY; Zheng RC; Zhou GB; Ma J; Feng JY; Zhong BL; Li YM
    Mol Med Rep; 2014 Jun; 9(6):2097-104. PubMed ID: 24718773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
    Ma L; Xue H; Qi R; Wang Y; Yuan L
    J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin impairs TLR7 signaling in dendritic cells and improves the severity of imiquimod-induced psoriasis-like skin inflammation in mice.
    Huang SW; Chen YJ; Wang ST; Ho LW; Kao JK; Narita M; Takahashi M; Wu CY; Cheng HY; Shieh JJ
    J Dermatol Sci; 2016 Oct; 84(1):59-70. PubMed ID: 27449383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-psoriatic effect of myeloid-derived suppressor cells on imiquimod-induced skin inflammation in mice.
    Kim CH; Yoo JK; Jeon SH; Lim CY; Lee JH; Koo DB; Park MY
    Scand J Immunol; 2019 Mar; 89(3):e12742. PubMed ID: 30548969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of different types of contact hypersensitivity on imiquimod-induced psoriasis-like inflammation in mice.
    Bai S; Zhang Z; Hou S; Liu X
    Mol Med Rep; 2016 Jul; 14(1):671-80. PubMed ID: 27221314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-17A and IL-23p19 antibodies but not anti-TNFα antibody induce expansion of regulatory T cells and restoration of their suppressive function in imiquimod-induced psoriasiform dermatitis.
    Shimizu T; Kamata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
    J Dermatol Sci; 2019 Sep; 95(3):90-98. PubMed ID: 31362906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen.
    Frenzel DF; Borkner L; Scheurmann J; Singh K; Scharffetter-Kochanek K; Weiss JM
    Exp Dermatol; 2015 Apr; 24(4):305-7. PubMed ID: 25655893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of pathogenesis of imiquimod-induced skin inflammation in the mouse: a role for interferon-alpha in dendritic cell activation by imiquimod.
    Ueyama A; Yamamoto M; Tsujii K; Furue Y; Imura C; Shichijo M; Yasui K
    J Dermatol; 2014 Feb; 41(2):135-43. PubMed ID: 24387343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of IL-27 in moderate-to-severe psoriasis and its anti-inflammation role in imiquimod-induced psoriasis-like mouse model.
    Chen W; Gong Y; Zhang X; Tong Y; Wang X; Fei C; Xu H; Yu Q; Wang Y; Shi Y
    J Dermatol Sci; 2017 Feb; 85(2):115-123. PubMed ID: 27939414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice.
    Sah SK; Park KH; Yun CO; Kang KS; Kim TY
    Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirubin ameliorates imiquimod-induced psoriasis-like skin lesions in mice by inhibiting inflammatory responses mediated by IL-17A-producing γδ T cells.
    Xie XJ; Di TT; Wang Y; Wang MX; Meng YJ; Lin Y; Xu XL; Li P; Zhao JX
    Mol Immunol; 2018 Sep; 101():386-395. PubMed ID: 30064075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Losartan ointment attenuates imiquimod-induced psoriasis-like inflammation.
    Shokrian Zeini M; Haddadi NS; Shayan M; Shokrian Zeini M; Kazemi K; Solaimanian S; Abdollahifar MA; Hedayatyanfard K; Dehpour AR
    Int Immunopharmacol; 2021 Nov; 100():108160. PubMed ID: 34583123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic and immunomodulatory effects of glucosamine in combination with low-dose cyclosporine a in a murine model of imiquimod-induced psoriasis.
    Kim CH; Kim JY; Lee AY
    Eur J Pharmacol; 2015 Jun; 756():43-51. PubMed ID: 25796200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.